Corvus Pharmaceuticals Inc (CRVS)
2.29
+0.10
(+4.57%)
USD |
NASDAQ |
May 17, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Corvus Pharmaceuticals Free Cash Flow: -20.98M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -20.98M |
December 31, 2023 | -23.97M |
September 30, 2023 | -26.35M |
June 30, 2023 | -28.11M |
March 31, 2023 | -29.01M |
December 31, 2022 | -27.29M |
September 30, 2022 | -26.60M |
June 30, 2022 | -27.83M |
March 31, 2022 | -34.35M |
December 31, 2021 | -36.72M |
September 30, 2021 | -38.07M |
June 30, 2021 | -37.45M |
March 31, 2021 | -34.29M |
December 31, 2020 | -34.85M |
September 30, 2020 | -35.16M |
June 30, 2020 | -37.96M |
March 31, 2020 | -37.69M |
Date | Value |
---|---|
December 31, 2019 | -37.35M |
September 30, 2019 | -37.22M |
June 30, 2019 | -37.57M |
March 31, 2019 | -39.30M |
December 31, 2018 | -41.34M |
September 30, 2018 | -43.92M |
June 30, 2018 | -43.78M |
March 31, 2018 | -44.67M |
December 31, 2017 | -46.48M |
September 30, 2017 | -45.53M |
June 30, 2017 | -41.50M |
March 31, 2017 | -36.66M |
December 31, 2016 | -30.06M |
September 30, 2016 | -24.84M |
June 30, 2016 | -21.41M |
March 31, 2016 | -16.68M |
December 31, 2015 | -13.08M |
Free Cash Flow Range, Past 5 Years
-38.07M
Minimum
Sep 2021
-20.98M
Maximum
Mar 2024
-32.44M
Average
-34.60M
Median
Free Cash Flow Benchmarks
Cyclacel Pharmaceuticals Inc | -16.12M |
Enanta Pharmaceuticals Inc | -113.29M |
Oragenics Inc | -7.291M |
Nanoviricides Inc | -6.203M |
MAIA Biotechnology Inc | -13.30M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -5.157M |
Cash from Investing (Quarterly) | -0.007M |
Free Cash Flow Per Share (Quarterly) | -0.1052 |
Free Cash Flow Yield | -18.84% |